SEK 75 million equity round bolsters enginzyme's commercial strategy
SEK 75 million equity round bolsters enginzyme's commercial strategy
SOLNA, Sweden, 22 Sept. 2026: Enginzyme AB gathered shareholders, stakeholders and employees on Sept. 17th to mark the closing of a new equity round of preference shares totalling SEK 75 million.
The round marks a key milestone in the company's shift from R&D to commercial production of biomanufactured products.
"With our growth strategy established, closing this new investment round was a priority for enginzyme," said Aymeric de Gantes, enginzyme's CEO. "We are also very excited to welcome new shareholders with complementary expertise, who will all contribute to our mission to deliver biomanufacturing solutions for the personal care, food, and pharmaceutical industries."
"Our technology enables lower cost in use for higher-quality ingredients, obtained through more sustainable manufacturing processes," he added.
Lotus One Investment Pte. Ltd. and Valquest Partners Europe are coming in as new shareholders and members of the Board of Directors. Sofinnova Partners, Stiftelsen Industrifonden, Navigare Ventures AB and Almi Invest GreenTech AB were key participants in the round, combined with several other new and existing shareholders.
“We're pleased to be progressing at pace with the plan we have set for the company, with a positive dynamic," said Chatarina Schneider, Chair of the Board. "We thank our existing shareholders and the different people who contributed to this important step.”
Michael Krel, Partner at Sofinnova Partners and an enginzyme Board member since 2020, said, "After a long journey, it is good to see the company progressing diligently on its conversion to commercial growth. It is also very positive to onboard new shareholders with such a strategic fit."
Asmita Dwivedi, the board member representing Lotus One Investment Pte. Ltd., said she was “glad to support Enginzyme's breakthrough science, coupled with a clear path to commercial scale and a strong management team. We see this investment as a meaningful step towards making chemistry cleaner and better."
Photo: On Thursday, Sept. 17, enginzyme hosted a gathering at its offices and labs in the Karolinska tech campus in Solna to bring together all of its stakeholders.
Read the official press release.
